Inloggen
Inloggen
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registreer
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

Toonaangevende leiders

HomepaginaAl het nieuwsHet meest gelezen nieuwsBiografieŽn van bedrijfsleiders 
Overzicht 
Su Ying Liu is a businessperson who founded Mountain Crest Acquisition Corp. and Mountain Crest Acquisition Corp. II and who has been the head of 6 different companies. Presently, Dr. Liu is Chairman, Chief Executive & Financial Officer at Mountain Crest Acquisition Corp. III, Chairman, Chief Executive & Financial Officer at Mountain Crest Acquisition Corp. IV, Chairman, Chief Executive & Financial Officer at Mountain Crest Acquisition Corp. V and President & Chief Executive Officer at MCAD Merger Sub, Inc. Dr. Liu is also on the board of Better Therapeutics LLC and Better Therapeutics, Inc.

In his past career Dr. Liu was Chief Strategist at Mansion Capital LLC, Chairman & Chief Executive Officer for Mountain Crest Acquisition Corp., Chairman & Chief Executive Officer at Mountain Crest Acquisition Corp. II and Head-Corporate Strategy at Hudson Capital, Inc.

Su Ying Liu received an undergraduate degree and a graduate degree from Washington University in St. Louis and a doctorate from Olin Business School.


Posities en verantwoordelijkheden van Su Ying Liu 
NaamTitel Van
Mountain Crest Acquisition Corp. V
(Holdingvennootschappen)
Chairman, Chief Executive & Financial Officer 2021
Mountain Crest Acquisition Corp. IV
(Holdingvennootschappen)
Chairman, Chief Executive & Financial Officer 2021
Mountain Crest Acquisition Corp. III
(Holdingvennootschappen)
Chairman, Chief Executive & Financial Officer 2021
Better Therapeutics, Inc.
(Biotechnologie & Medisch Onderzoek)
Director 2021
MCAD Merger Sub, Inc. President & Chief Executive Officer -
Better Therapeutics LLC Director -


Belangnemingen van Su Ying Liu 
NaamAandelen%Totale waarde
Mountain Crest Acquisition Corp. V (MCAGU)
(Holdingvennootschappen)
1 840 80025,8%19 484 868 USD
Better Therapeutics, Inc. (BTTX)
(Biotechnologie & Medisch Onderzoek)
14 2500,060%22 088 USD


Su Ying LiuPersoonlijk netwerk 
Meest gelezen nieuws 
21/11Buffett's Berkshire vergroot belangen in vijf grootste Japanse handelshuizen
MR
23/11Berkshire Hathaway zegt dat Warren Buffett aandelen schenkt aan goede doelen in de familie
MR
01/12Salesforce-aandelen tuimelen na verrassende exit van mede-CEO Taylor
MR
30/11Meta's Zuckerberg zegt dat sommige van Elon Musks Twitter-contentaanpak 'zou kunnen werken'.
MR
18/11Gates Foundation belooft 7 miljard dollar voor Afrika nu oorlog in Oekraïne donorgeld afleidt
MR
30/11Juventus heeft geen behoefte aan extra kapitaal, zegt Elkann van Exor
MR
19/11Musk's loonproces vraagt of Tesla's groei 56 miljard dollar compensatie rechtvaardigt
MR
22/11Boomerang CEO's' werken niet altijd; Disney hoopt dat deze CEO de trend doorbreekt.
MR
22/11Musk zegt dat Twitter de herlancering van blue check-verificatie uitstelt
MR
20/11Musk's Twitter poll laat zien dat krappe meerderheid Trump opnieuw wil laten optreden
MR
Meer nieuws


© 2022 People and Ownership :   
Su Ying Liu Verbindingen